Literature DB >> 24502678

Mental capacity in patients involuntarily or voluntarily receiving psychiatric treatment for an acute mental disorder.

Gabriele Mandarelli1, Lorenzo Tarsitani, Giovanna Parmigiani, Gian M Polselli, Paola Frati, Massimo Biondi, Stefano Ferracuti.   

Abstract

Despite the growing amount of data, much information is needed on patients' mental capacity to consent to psychiatric treatment for acute mental disorders. The present study was undertaken to compare differences in capacity to consent to psychiatric treatment in patients treated voluntarily and involuntarily and to investigate the role of psychiatric symptoms, competency, and cognitive functioning in determining voluntariness of hospital admission. Involuntary patients were interviewed with the MacArthur Competence Assessment Tool for Treatment (MacCAT-T), the 24-item Brief Psychiatric Rating Scale (BPRS), the Mini Mental State Examination (MMSE) and the Raven's Colored Progressive Matrices, and their data were compared with those for age- and sex-matched voluntary patients. Involuntary patients performed worse in all MacCAT-T subscales. Capacity to consent to treatment varied widely within each group. Overall, involuntary patients have worse consent-related mental capacity than those treated voluntarily, despite capacity to consent to treatment showing a significant variability in both groups.
© 2014 American Academy of Forensic Sciences.

Entities:  

Keywords:  affective disorders; forensic science; health care ethics; informed consent; mental competency; schizophrenia

Mesh:

Year:  2014        PMID: 24502678     DOI: 10.1111/1556-4029.12420

Source DB:  PubMed          Journal:  J Forensic Sci        ISSN: 0022-1198            Impact factor:   1.832


  8 in total

1.  Treatment decision-making capacity in non-consensual psychiatric treatment: a multicentre study.

Authors:  G Mandarelli; F Carabellese; G Parmigiani; F Bernardini; L Pauselli; R Quartesan; R Catanesi; S Ferracuti
Journal:  Epidemiol Psychiatr Sci       Date:  2017-03-09       Impact factor: 6.892

2.  The capacity of schizophrenia and bipolar disorder individuals to make autonomous decisions about pharmacological treatments for their illness in real life: A scoping review.

Authors:  Enric Vincens Pons; Luis Salvador-Carulla; Alfredo Calcedo-Barba; Silvia Paz; Thomas Messer; Bruno Paccardi; Scott L Zeller
Journal:  Health Sci Rep       Date:  2020-08-09

3.  Retrospective Chart Review of Voluntary Admissions to an Inpatient Psychiatric Hospital in New York City: A Demographic Breakdown.

Authors:  Amir Garakani; Brianna M Cerrito; Amy S Aloysi; Jose M Martinez; Frank D Buono
Journal:  Community Ment Health J       Date:  2019-10-25

4.  European Psychiatric Association policy paper on ethical aspects in communication with patients and their families.

Authors:  Bernardo Carpiniello; Danuta Wasserman
Journal:  Eur Psychiatry       Date:  2020-04-01       Impact factor: 5.361

5.  Translating clinical findings to the legal norm: the Defendant's Insanity Assessment Support Scale (DIASS).

Authors:  Giovanna Parmigiani; Gabriele Mandarelli; Gerben Meynen; Felice Carabellese; Stefano Ferracuti
Journal:  Transl Psychiatry       Date:  2019-11-07       Impact factor: 6.222

6.  Ethical Challenges in Health Care Policy during COVID-19 Pandemic in Italy.

Authors:  Davide Ferorelli; Gabriele Mandarelli; Biagio Solarino
Journal:  Medicina (Kaunas)       Date:  2020-12-11       Impact factor: 2.430

7.  Antipsychotic Polypharmacy and High-Dose Antipsychotic Regimens in the Residential Italian Forensic Psychiatric Population (REMS).

Authors:  Gabriele Mandarelli; Felice Carabellese; Guido Di Sciascio; Roberto Catanesi
Journal:  Front Psychol       Date:  2022-02-10

8.  Treatment Decision-Making Capacity in Children and Adolescents Hospitalized for an Acute Mental Disorder: The Role of Cognitive Functioning and Psychiatric Symptoms.

Authors:  Gabriele Mandarelli; Ugo Sabatello; Elisa Lapponi; Giulia Pace; Mauro Ferrara; Stefano Ferracuti
Journal:  J Child Adolesc Psychopharmacol       Date:  2016-12-09       Impact factor: 2.576

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.